CASERINI, Maurizio,MAILLAND, Federico,SCARCI, Francesco
申请号：
TN2015000431
公开号：
TN2015000431A1
申请日:
2015.09.17
申请国别(地区):
TN
年份:
2017
代理人:
摘要：
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
